| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 28.37B | 28.61B | 28.70B | 28.22B | 24.61B | 17.30B |
| Gross Profit | 15.24B | 15.50B | 14.92B | 14.32B | 12.95B | 7.15B |
| EBITDA | -2.10B | -1.90B | 797.00M | 10.70B | -2.21B | -1.42B |
| Net Income | -2.60B | -2.48B | 291.00M | 6.76B | -3.54B | -4.51B |
Balance Sheet | ||||||
| Total Assets | 35.40B | 37.40B | 40.88B | 39.76B | 31.80B | 35.39B |
| Cash, Cash Equivalents and Short-Term Investments | 5.53B | 7.88B | 5.38B | 13.55B | 5.47B | 7.72B |
| Total Debt | 12.46B | 14.04B | 14.78B | 11.83B | 13.51B | 15.23B |
| Total Liabilities | 26.18B | 25.20B | 26.24B | 25.26B | 24.09B | 24.77B |
| Stockholders Equity | 8.59B | 11.54B | 13.98B | 13.86B | 7.05B | 9.68B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -338.00M | -12.44B | -691.00M | -1.27B | -337.00M |
| Operating Cash Flow | 0.00 | 500.00M | -1.88B | 19.00M | -481.00M | 95.00M |
| Investing Cash Flow | 0.00 | 2.80B | -7.90B | 10.22B | 132.00M | 5.58B |
| Financing Cash Flow | 0.00 | -905.00M | 1.49B | -2.37B | -2.01B | -1.47B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥195.02B | 13.54 | 10.24% | 2.43% | 6.08% | 8.55% | |
75 Outperform | ¥917.49B | 23.81 | 11.10% | 0.99% | 9.49% | 55.64% | |
75 Outperform | ¥121.70B | 24.35 | ― | 1.79% | 10.76% | 54.82% | |
74 Outperform | ¥128.76B | 15.85 | ― | 2.66% | 7.56% | -17.12% | |
66 Neutral | ¥154.86B | 48.89 | 2.34% | 3.38% | >-0.01% | -49.83% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
55 Neutral | ¥35.23B | -12.94 | ― | 8.83% | -0.88% | -609.34% |